View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results...

IRADIMED CORPORATION Announces First Quarter of 2024 Financial Results and the Declaration of its Regular Quarterly Cash Dividend of $0.15 Per Share Reports record revenue of $17.6 million for the first quarter of 2024.Reports GAAP diluted EPS of $0.32 and non-GAAP diluted EPS of $0.36 for the first quarter of 2024.Reports first quarter of 2024 operating income of $4.7 million, an increase of 18.5 percent compared to the same period in 2023.Declares a regular quarterly cash dividend of $0.15 per common share for the second quarter of 2024, payable May 30, 2024. WINTER SPRINGS, Fla., May ...

Dime Community Bancshares Inc: 1 director

A director at Dime Community Bancshares Inc sold 8,751 shares at 0.000USD and the significance rating of the trade was 51/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...

 PRESS RELEASE

Universal Reports First Quarter 2024 Results

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- Universal Insurance Holdings (NYSE: UVE) (“Universal” or the “Company”) reported first quarter 2024 results. “It was a strong quarter, including a 29.4% annualized adjusted return on common equity and 35.4% adjusted diluted EPS growth year-over-year,” said Stephen J. Donaghy, Chief Executive Officer. “Results were solid across the board, including profitable underwriting that was complemented by our non-underwriting operations, which is a testament to our differentiated business model. Direct premiums written growth accelerated sequentially, as polici...

 PRESS RELEASE

IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conf...

IRADIMED CORPORATION to Hold 2024 First Quarter Financial Results Conference Call on May 2nd WINTER SPRINGS, Fla., April 25, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2024 first quarter financial results before the market opens on Thursday, May 2, 2024. Iradimed management will host a conference call the same day beginning at 11:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, . Once registered, a dial-i...

 PRESS RELEASE

Universal Declares Regular Cash Dividend & Announces Earnings Dates

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- Universal Insurance Holdings, Inc. (NYSE: UVE) (“Universal” or the “Company”) announced today that its Board of Directors has declared a quarterly cash dividend of 16 cents per share of common stock, payable May 17, 2024 to shareholders of record as of the close of business on May 10, 2024. Universal will issue a press release reporting its first quarter 2024 results after the market closes on Thursday, April 25, 2024. The company will host a conference call on Friday, April 26, 2024, at 10:00 a.m. ET to discuss financial results. Investors and othe...

Assured Guaranty Ltd: 1 director

A director at Assured Guaranty Ltd sold 55,000 shares at 92.435USD and the significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years cl...

 PRESS RELEASE

IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference

IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference WINTER SPRINGS, Fla., March 13, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD) today announced that Roger Susi, the Company's President and Chief Executive Officer, will present at the 36th Annual Roth Conference in Laguna Niguel, CA. Mr. Susi is scheduled for a live fireside chat on Tuesday, March 19, at 12:30 p.m. PT. A live webcast and a replay of the fireside chat will be available on Iradimed’s Investor page at . This year’s event will consist of 1-on-1 / small group meetings, analy...

 PRESS RELEASE

Universal Announces New $20 Million Share Repurchase Authorization

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- Universal Insurance Holdings, Inc. (NYSE: UVE) (“Universal” or the “Company”) announced today that its Board of Directors has authorized a new share repurchase program under which the Company may repurchase up to $20 million of its outstanding shares of common stock through March 11, 2026. Share repurchases may be made by the Company from time to time in open market transactions at prevailing market prices. The Company intends to effect repurchase transactions in compliance with Rule 10b-18 under the Securities Exchange Act of 1934 and the Company’s i...

Moelis & Co: 4 directors

Two Directors at Moelis & Co sold after exercising options 78,828 shares at between 54.046USD and 54.130USD. The significance rating of the trade was 72/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company'...

 PRESS RELEASE

Universal Reports Fourth Quarter 2023 Results

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- Universal Insurance Holdings (NYSE: UVE) (“Universal” or the “Company”) reported fourth quarter and full year 2023 results. “We closed out both the fourth quarter and full year with double-digit adjusted returns on common equity and I believe that even stronger results are firmly in our future,” said Stephen J. Donaghy, Chief Executive Officer. “2023 was a transformative year for us and our significant efforts position us for meaningful success in the new legislative environment. We’ve added a buffer to our loss picks and bolstered reserves for years ...

 PRESS RELEASE

Universal Declares Regular Cash Dividend & Announces Earnings Dates

FORT LAUDERDALE, Fla.--(BUSINESS WIRE)-- Universal Insurance Holdings, Inc. (NYSE: UVE) (“Universal” or the “Company”) announced today that its Board of Directors has declared a quarterly cash dividend of 16 cents per share of common stock, payable March 15, 2024 to shareholders of record as of the close of business on March 8, 2024. Universal will issue a press release reporting its fourth quarter 2023 results after the market closes on Thursday, February 22, 2024. The company will host a conference call on Friday, February 23, 2024, at 10:00 a.m. ET to discuss financial results. Investor...

 PRESS RELEASE

IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of...

IRADIMED CORPORATION Announces Fourth Quarter of 2023 and Full Year of 2023 Financial Results Reports record revenue of $17.5 million for the fourth quarter and $65.6 million for the full year of 2023. Reports GAAP diluted EPS of $0.36 and non-GAAP diluted EPS of $0.39 for the fourth quarter of 2023. Reports GAAP diluted EPS of $1.35 and non-GAAP diluted EPS of $1.48 for the full year of 2023. Reports fourth quarter of 2023 operating income of $5.2 million, an increase of 21.3%, compared to the same period in 2022 and full-year operating income of $20.0 million, an increase of 28.2%, com...

 PRESS RELEASE

IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Con...

IRADIMED CORPORATION to Hold 2023 Fourth Quarter Financial Results Conference Call on February 8th. WINTER SPRINGS, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD) announced today that the Company will release its 2023 fourth quarter financial results before the market opens on Thursday, February 8, 2024. Iradimed management will host a conference call the same day beginning at 9:00 a.m. Eastern Time to discuss those results and to answer questions. Individuals interested in participating in the conference call may do so by registering here, .Once registered, ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Continue Riding This Bull Market Higher Since early November 2023 we have laid out our bullish expectations for a year-end rally that we anticipated would continue into the early part of 2024. Here we are in the early part of 2024, and we see every reason to continue riding this bull market higher. Small- and Mid-Caps Resuming Uptrends. Looking at the big picture on the small-cap Russell 2000 (IWM) and the Vanguard Extended Market ETF (VXF, the entire U.S. market excluding the S&P 500), (1) th...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

Breakouts Proliferate; Bullish Outlook Intact The S&P 500, Nasdaq 100, and DJI are breaking out to new all-time highs following 3-week consolidations, while the small-cap Russell 2000 (IWM), mid-cap S&P 400 (IJH), Vanguard Extended Market ETF (VXF), and countless other Sectors/industries are breaking out from 3-week bullish falling wedge/flag patterns. This is classic bull market behavior. Considering market dynamics remain healthy, this is all evidence that supports our ongoing bullish outlook...

 PRESS RELEASE

IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue

IRADIMED CORPORATION Reports Unaudited Fourth Quarter and 2023 Revenue Reports preliminary fourth quarter 2023 revenue of $17.5 million WINTER SPRINGS, Fla., Jan. 09, 2024 (GLOBE NEWSWIRE) --  IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in developing innovative Magnetic Resonance Imaging (‘MRI”) compatible medical devices, today reported unaudited revenue for the fourth quarter and fiscal year ended December 31, 2023. The fourth-quarter revenue totaled approximately $17.5 million, bringing revenue for 2023 to approximately $65.6 million, up 23% from the prior year. “We...

 PRESS RELEASE

IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthc...

IRADIMED CORPORATION To Present at the 42nd Annual J.P. Morgan Healthcare Conference WINTER SPRINGS, Fla., Jan. 02, 2024 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the “Company”) (NASDAQ: IRMD), a leader in developing innovative Magnetic Resonance Imaging (“MRI”) compatible medical devices, today announced that the Company will be participating in the upcoming 42nd Annual J.P. Morgan Healthcare Conference. Iradimed’s CEO, Roger Susi, is scheduled to present on Thursday, January 11, 2024, at 12:00 p.m. Pacific Time. Interested parties may access a live and archived webcast of the prese...

Iradimed Corp: 1 director

A director at Iradimed Corp sold 10,000 shares at 46.255USD and the significance rating of the trade was 55/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly s...

 PRESS RELEASE

IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend o...

IRADIMED CORPORATION Announces Establishment of a Quarterly Dividend of $0.15 per share and a Special Cash Dividend of $0.48 per share WINTER SPRINGS, Fla., Dec. 12, 2023 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (the "Company") (NASDAQ: IRMD) announced today that its Board of Directors approved a special cash dividend of $0.48 per share and the initiation of a regular quarterly dividend on the Company's outstanding common stock. The regular quarterly dividend is $0.15 per share. The special cash dividend and the quarterly dividend are payable on January 12, 2024, to shareholders of record...

Cadence Bank: 1 director

A director at Cadence Bank sold 45,000 shares at 27.130USD and the significance rating of the trade was 74/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly sh...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch